425: Strive & Semler Scientific Merger Communication

Strive, Inc. and Semler Scientific, Inc. issued a communication regarding their proposed business combination, emphasizing forward-looking statements and associated risks.

Summary

• A communication from Strive, Inc. regarding its proposed business combination with Semler Scientific, Inc. was reposted on X.com by Strive's CFO, Ben Pham, on December 22, 2025.
• The communication includes a cautionary statement about forward-looking statements related to the merger's outlook, strategic and financial benefits, timing, and integration.
• Investors are urged to read the Registration Statement on Form S-4, Information Statement/Proxy Statement/Prospectus, and other relevant SEC filings for important information about the proposed transaction.
• Details are provided on where to find these documents, including the SEC's website, company websites, and investor relations departments.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement regarding a proposed merger. While it outlines potential benefits, it heavily emphasizes numerous risks and uncertainties, including dilution and potential delays, leading to a neutral sentiment.

Positives

• The proposed transaction aims to achieve strategic and financial benefits for the combined company.
• The companies anticipate successful integration of their businesses.

Negatives

• The proposed transaction may be more difficult, time-consuming, or costly than expected.
• Anticipated benefits, including cost savings and strategic gains, may not be realized.
• Management's attention may be diverted from ongoing business operations.
• Potential adverse reactions from customers or changes to business/employee relationships.
• Dilution caused by Strive's issuance of additional Class A common stock.

Risks

• The merger agreement could be terminated by either Strive or Semler Scientific.
• Conditions to closing the proposed transaction may not be received or satisfied on a timely basis or at all.
• Potential legal proceedings may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized, potentially due to changes in or problems arising from Bitcoin treasury strategies and risks associated with digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations could impact the realization of benefits.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution for existing shareholders due to Strive's issuance of additional Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The companies have expectations regarding the proposed transaction's strategic and financial benefits, its impact on future financial performance, the timing of closing, and the ability to successfully integrate the combined businesses. However, these forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially from anticipated results.

Management Comments

• Ben Pham, Chief Financial Officer of Strive, Inc., reposted the communication on X.com on December 22, 2025, in connection with the proposed business combination.

Industry Context

The filing highlights potential risks associated with 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets,' indicating that the combined entity may be involved in or exposed to the cryptocurrency market, which is a significant and volatile industry trend.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.

Stakeholder Impact

• Shareholders: Potential dilution caused by Strive's issuance of additional shares of its Class A common stock and potential changes in share price before closing.
• Customers: Potential adverse reactions from Strive's or Semler Scientific's customers.
• Employees: Potential changes to business or employee relationships.

Next Steps

• Strive and Semler Scientific will continue to work towards satisfying the conditions for closing the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement on Form S-4 and Information Statement/Proxy Statement/Prospectus for comprehensive information.
• A definitive Information Statement/Proxy Statement/Prospectus was sent to Semler Scientific stockholders to seek their approval of the proposed transaction.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Bitcoin Treasury, Digital Assets, Corporate Governance, Shareholder Dilution